Skip to content
Home/Companies/MedTech/Akina
Akina

Akina

MedTech·Switzerland·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Akina?

Akina is currently owned by Freigeist Capital through Freigeist Deep-Tech Evergreen (2017 vintage), since 2025.

Hand-verified · updated 2026-07-03

Freigeist Capital
Investor
Freigeist Capital
Freigeist Deep-Tech Evergreen · 2017 · Evergreen

Key facts

HQSwitzerland
SectorMedTech
StatusActive
Websitewww.akina.health

More from Freigeist Deep-Tech Evergreen

Other portfolio companies in the same fund.

Collie
Collie
Active
SoftwareGermany· 2025
BioThrust
Active
BiotechGermany· 2024
United Manufacturing Hub
Active
SoftwareGermany· 2024
Leko Labs
Active
ConstructionLuxembourg· 2022
Prosion
Prosion
Active
BiotechGermany· 2022
BUILD.ONE
Build.one
Active
SoftwareGermany· 2021

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Track Akina

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Akina?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Akina.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue